Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BTMDthis companybiote Corp.	$1.05	3.02×	-1.39×	0.42×	3.2×	833.7%	71.5%	18.5%	14.1%	-46.2%	43.0%	37.1%	-1.88×	1.64×	3.24×	1.22×	2.1%	7	2.08	3	B-
ABOSAcumen Pharmaceuticals, Inc.	$0.24	-1.06×	1.81×	0×	-0.9×	56.7%	0.0%	0.0%	0.0%	-172.3%	-121.7%	-90.5%	0.44×	0.19×	-29.32×	4.07×	0.0%	2	-11.67	2	C
ACTUActuate Therapeutics Inc	$0.34	-5.77×	16.24×	0×	-5.22×	57.8%	0.0%	0.0%	0.0%	-280.5%	-270.1%	-14.9%	0.05×	0.57×	-1,110.88×	2.39×	0.0%	2	-56.06	2	C
ANIKAnika Therapeutics, Inc.	$14.53	-12.64×	0.96×	1.22×	-29.78×	-96.9%	56.6%	-9.8%	-9.6%	-7.6%	-6.5%	3.2%	0.18×	8.73×	0×	4.72×	0.0%	5	4.93	2	B-
INOInovio Pharmaceuticals, Inc.	$1.51	-0.96×	3.39×	1,248.52×	-0.57×	-63.4%	100.0%	-132871.3%	-130000.0%	-352.5%	-259.4%	-109.0%	0.39×	0.43×	0×	1.4×	0.0%	0	-54.95	1	C-
JYNTThe Joint Corp.	$6.64	45.89×	8.77×	2.4×	74.37×	-64.1%	79.6%	-1.6%	5.3%	19.3%	-3.2%	0.3%	0.13×	-14.55×	0×	1.59×	0.0%	8	2.85	3	B+
Peer median	—	-1.06×	3.39×	1.22×	-0.9×	-63.4%	56.6%	-1.6%	0.0%	-172.3%	-121.7%	-14.9%	0.18×	0.43×	0×	2.39×	0.0%	2	-11.67	2	—